INTRODUCTION
The bacterial superantigen (SAg) family is a large protein family exclusive to three pathogenic species: Staphylococcus aureus, Streptococcus pyogenes and Streptococcus equi.
The former two organisms are opportunistic human pathogens and the latter is a pathogen of horses. Members of this family of proteins have been implicated in a range of human diseases, including staphylococcal food poisoning, scarlet fever, toxic shock, rheumatoid arthritis and secondary HIV infection (1) . Streptococcus equi is the causative agent of strangles in horses (2) . Superantigens function by immune modulation. They cross-link major histocompatability complex class II (MHC-II) and T-cell receptor (TCR) molecules, causing non-specific and disproportionate T-cell proliferation and cytokine release (3) . This gives rise to symptoms characteristic of fever and toxic shock. As a result of their close association with serious human pathologies, superantigens have been the subject of intense research over the last decade and several reviews have been published (3) (4) (5) .
The identification of a Staphylococcal gene cluster (6) and the determination of the complete genome sequence of S. aureus (7) have revealed a family of genes with similarity to superantigens from Staphyloccocus aureus. These were first described by Williams and colleagues (6) , as a cluster of five related genes whose protein products were reported to is flanked at the 5' end by a putative transposase and is also thought to be maintained in the genome by two genes, hsdS and hsdM, which are part of a three component restrictionmodification system.
The SET genes are most closely related, by sequence, to toxic shock syndrome toxin (TSST), which is a Staphylococcal superantigen. The overall sequence identity is low, at only 26%, but there are small regions which are very well conserved when compared to superantigens.
Thus, the SET proteins carry the SAg signature sequences. Previous structural and functional studies of superantigens have revealed the capacity for these proteins to graft a wide variety of functional modes onto a conserved fold (5, 8) . For example, different superantigens variously bind to MHC-II molecules via their N-terminal domain (SEB, TSST) (9, 10) or via a zinc atom bound on the surface of their C-terminal domain (SMEZ-2, SPE-C) (11) . They are able to cross-link MHC-II molecules at the cell surface by simultaneous N-and C-terminal binding in the case of SEA (12) or by dimerisation in the case of SPE-C (13) . The superantigens also show allelic variation amongst strains (SMEZ-2) (14) and varying degrees of specificity for alleles of the TCR (15) .
The availability of genomic sequence data has transformed our knowledge of the distribution of superantigens and superantigen-like proteins in bacterial species. The completion of the conserved among the other SET proteins, there is evidence that they do not function as prototypic superantigens. We also show, however, that they are likely to have a significant role in host/pathogen interactions in humans, because seroconversion is widespread and antibody titres in human serum are high in the majority of tested cases. I in 20 µl of 5xPBS and 5 µl 1 mg.ml -1 Chloramine T, and incubated for 1 min. 5 µl of 5 mg.ml -1 sodium metabisulphite was added to this solution and the volume made up to 50 µl with PBS/1% FCS. This was then loaded on to a 1 ml G25 column pre-equilibrated with PBS/1% FCS and the protein was eluted in 100 µl fractions. An aliquot from each fraction (1 µl) was counted using a Cobra II gamma counter.
EXPERIMENTAL PROCEDURES
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Immunoprecipitation to detect for seroconversion. 5 µl of human serum was incubated with 10 5 cpm SET3 125 I in a total volume of 50 µl TSA/10%FCS/1% Hb at 37 ˚C for 30 min. 5 µl of protein A-sepharose was added and the sample incubated on ice for 30 min. After washing 3 times in 0.5 ml RIPA buffer, the sample was analysed using a Cobra II gamma counter. A control containing no serum was used to determine the background count.
Western Analysis of S. aureus culture supernatants. Staphylococcus aureus clinical isolates
were cultured overnight without shaking at 37˚C. After centrifugation to remove the bacteria, 0.5 ml of culture supernatant was concentrated by precipitation with 50% TCA and resuspended in 5 µl PBS. Samples were subjected to electrophoresis on a 12% SDS-PAGE protein gel. The proteins were transferred to nitrocellulose using a semi-dry blotter. The membrane was blocked for 1 hour at room temperature in TTBS/5% (w/v) non-fat milk powder. A 1/500 dilution of mouse anti-SET3 polyclonal serum was then incubated with the membrane for 1 hour at room temperature in blocking buffer. After washing in TTBS the membrane was incubated with a 1/1000 dilution of peroxidase labelled anti-mouse IgG for 1 hour at room temperature. The membrane was then washed in TBS and analysed using an ECL Western blotting detection kit from Amersham Pharmacia Biotech. X-ray data collection. Native and derivative data sets for SET3 were collected using CuKα radiation from a Rigaku RU-H3R X-ray generator equipped with focussing mirrors and a Mar345 imaging plate detector. Subsequently, a high resolution native data set was collected using sychrotron radiation (λ = 0.8452 Å) at DESY Hamburg, beamline BW7V. The raw data were processed using DENZO and subsequently scaled using SCALEPACK (18) . Data collection statistics are given in Table 1 .
PBL proliferation assay.
Structure determination and refinement. round of phased refinement indicated that the symmetry constraints of P6 3 22 were too high and the space group symmetry was therefore lowered to P6 3 with two molecules in the asymmetric unit. The model, now comprising 218 residues, was used to determine initial phases for WARP (23) and the remainder of the two molecules were built automatically by WARP using data in the resolution range 30 -1.90 Å. Finally, five iterations of manual building and refinement using O and CNS (24) were undertaken to finish the structure determination. Final statistics are given in Table 2 . Structural comparisons were performed using the program MAPS (http://bioinfo1.mbfys.lu.se/TOP/maps.html; Lu, 1998) and comparison trees were constructed from structure diversity scores as previously described (8).
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RESULTS
Quality of the Structural Model. The three-dimensional structure of SET3 was determined by X-ray crystallography and refined using data to Lys60 are central residues in type II' β-turns and this accounts for their unusual φ/ψ angles (see Figure 2 ). Asp118 is part of the tight turn that links β-strands β6 and β7. However, Lys60 is part of a β-turn which does not link secondary structure elements and is flanked on both sides by loops. Asp104 lies between two tyrosine residues in a tightly-packed structure that includes one leucine and three tyrosine residues, which may constrain Asp104 in its unusual φ/ψ geometry. This Asp residue is conserved in 6 out of 10 SET proteins. The electron density for each of these three residues (Asp118, Lys60, Asp104) in each SET molecule in the asymmetric unit is unequivocal and, at least in the case of Lys60 and Asp104,
Arcus et al. The SET3 structure has two notable features that differentiate it from other SAg-family proteins whose structures have been solved to date. First, the strands β6 and β7 in the Cterminal domain are extended so that the β6-β7 loop projects from the molecular surface (the strands flank D118, Figure 2 ). In the crystal, the two independent molecules in the asymmetric unit are related by a pseudo two-fold axis about β7, and this extended loop forms a β-sheet with the same loop of the second molecule. The surface area buried in the crystallographic dimer interaction is small (287 Å 2 per monomer) and it appears that this "dimer" does not persist in solution, since dynamic light scattering indicates a monomer.
However, the formation of this dimer includes 6 intermolecular hydrogen bonds and constructs a large and continuous β-sheet of 10 strands between the two monomers. This, in turn, presents a large, positively charged, saddle-shaped surface ( Figure 2 ) that has the potential to act as a binding surface for negatively charged molecules such as DNA. This highlights a second striking feature of the structure, in the widespread positive charge over Arcus et al.
the protein surface. Although lysine and arginine residues are scattered across the surface they are concentrated at the capping helix and outer face of the N-terminal OB-fold domain, and in the saddle-shaped face formed by the association of the two molecules in the asymmetric unit described above. We suggest that these areas are likely binding sites for negatively charged binding partners.
Comparison with other superantigens. Proteins from the superantigen family are well represented in the current structural database, SET3 being the fourteenth such structure from this family to be determined. When these proteins are compared as a whole, it is apparent that the structural core is conserved, with 76 residues occupying equivalent Cα positions, with a root-mean-square (rms) difference of 1.15 Å (for those 76 residues), but with only five residues conserved at the sequence level. SET3 and TSST form an out-group from the remainder of the SAg-like proteins, such that if these two structures are omitted from the alignment, 113 residues share equivalent Cα positions (with an rms difference of 0.95 Å for those 113 residues) and 16 residues are conserved in the sequence. These 16 residues appear to be conserved for their role in preserving the superantigen fold, and apart from glycines are almost exclusively involved in buried charge-charge or polar interactions between elements of secondary structure. Most are concentrated around the interdomain region and appear to help maintain the close association of the two domains.
When the SET3 and TSST structures are overlaid, 127 Cα positions are within 3.5 Å with an rms difference of 1.15 Å, with 37 sequence identities in this conserved core. Again, the majority of the residues that are conserved in sequence and in structure between TSST and SET3 play clear structural roles either contributing to the hydrophobic core, or with their side chains forming buried charge-charge interactions or hydrogen bonds with main-chain atoms.
The exceptions to this are Lys114, Lys160 and Glu200 (SET3 numbering), all on the outer face of the C-terminal β-grasp domain, and Asn150, Asp16 and Asp19, on the opposite face of the β-grasp domain, in proximity to the N-terminal helix. These six residues do not, however, correspond to any equivalent residues in TSST that are involved in either MHC-II binding or TCR interactions (10) . In this context, the structure suggests that it is most unlikely that SET3 could bind to either MHC-II or the TCR in a manner similar to TSST. For example, 15 residues from TSST interact with MHC-II upon binding (10) and, after structural alignment, just 2 of these residues are conserved between TSST and SET3 (see Figure 3) . Of the remaining 13 MHC-II binding residues, the differences between TSST and SET3 include Asp→Tyr, Arg→Ile, Leu→Arg and Pro→Gly. These non-conservative changes at the binding face argue strongly against any similar binding of SET3 to MHC II.
There are other significant structural differences between TSST and SET3. In comparison to TSST, SET3 has an elongated loop (residues 37-42) that connects strands β1 and β2 on the surface of its N-terminal domain. In SET3, the N-terminal β-barrel is also capped by an α-helix (residues 58-68, linking β3 and β4) that is missing in TSST but present in all the other superantigens and is also a general feature of the OB-fold (25, Figure 3 ). The loop that leads into the C-terminal domain, residues 99-107, has a very different conformation in SET3 when compared with TSST. In SET3 this loop is solvent-exposed and contains Asp104, which occupies a generously allowed region of the Ramachandran plot and may be important for SET3 function. As described above, SET3 also has elongated β-strands, β6 and β7, at the periphery of the C-terminal β-sheet (residues 116-129). Figure 4) . Five of the 37 residues are buried hydrophobic residues and their allelic variants are also hydrophobic, but all other residues are surface exposed. Allelic variation has also been reported for SET1 and is suggested by the sequence differences between the allelic pairs SET1/11, SET2/8, SET3/10, SET4/14 and SET5/13.
The SET family of proteins are not superantigens. Three recombinant proteins from the SET family, SET1, SET3 and SET15, were used in a typical peripheral blood lymphocyte (PBL) stimulation assay in order to assess their mitogenicity. The ability to stimulate the proliferation of T-cells in a TCR Vβ-restricted manner is a hallmark of superantigens. TSST was used as a positive control, and reaches maximum stimulation at 1 ng.ml -1 . In all cases and at all concentrations, however, the SET proteins showed no capacity to induce T-cell proliferation (see Figure 5 ).
SET3 is secreted by all Staphylococcus aureus isolates. Polyclonal antibodies to the SET
proteins were raised in mice. α-SET3 was used to detect for the presence of SET3 in the culture supernatants of six S. aureus clinical isolates. These isolates were randomly chosen from a panel of 20 clinical isolates, all of which were found to be positive for the SET3 gene by PCR. Western analysis of the supernatants, concentrated 50 times by TCA precipitation,
shows that SET3 is secreted by S. aureus in all cases (see Figure 6 ).
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SET3 is recognised by the human immune system. Radioactively labelled SET1 and SET3
were immunoprecipitated using a panel of human sera together with protein A-sepharose.
Serum from 15 healthy individuals was incubated with radioactively labelled SETs to detect
for the presence of antibodies against these proteins. All individuals showed positive seroconversion indicating that they have all been exposed to these proteins at some time (see Figure 7 ).
DISCUSSION
The set family of genes encode a new and large family of SAg-like proteins. As a family they are most closely related to TSST by sequence, and the 9-10 set genes lie consecutively on the Staphylococcus aureus genome (7), almost certainly as a result of gene duplications.
Divergence of these genes within the genome is marked and, as is characteristic of the whole superantigen family with which they share sequence similarity, is presumed to have given rise to structurally homologous proteins with different, but related, functions.
The structure of SET3, the first from this family, and the first from the SaPIn2 pathogenicity island in the S. aureus genome, shows clearly that this protein, and by implication, the other SET proteins, belongs to the wider superantigen superfamily. The most striking feature of this superfamily is the diversity of functions (and sequences) supported by their highly conserved structural framework (5, 8) . Sequence conservation is limited to residues that confer structural integrity, particularly in and around the interdomain region, whereas the protein surfaces vary considerably. Variations include changed external loops and metal binding sites, in addition to changes in specific surface residues, and lead to differences in 
